A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

January 31, 2006

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

ABT-751

Trial Locations (17)

38120

West Cancer Clinic, Memphis

64111

Oncology & Hematology Associates of Kansas City, PA, Kansas City

Unknown

Oncology Hematology Group of South Florida, Miami

Florida Cancer Institute, New Port Richey

Albany Regional Cancer Center, Albany

Raleigh Hematology Oncology, Cary

Dayton Oncology and Hematology, Kettering

Cancer Care Associates, Oklahoma City

Cancer Centers of the Carolinas, Greenville

Texas Oncology, Dallas

Texas Oncology, Fort Worth

Cancer Care Northwest, Spokane

Northwest Cancer Specialists, Vancouver

60637-1460

University of Chicago Medical Center, Chicago

21201-1595

University of Maryland Greenbaum Cancer Center, Baltimore

63110-1093

Washington University School of Medicine, St Louis

53792-5666

University of Wisconsin Comprehensive Cancer Center, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY